🇺🇸 FDA
Pipeline program

Placebo

AC-201CR-HA-001

Phase 2 small_molecule completed

Quick answer

Placebo for Hemophilic Arthropathy is a Phase 2 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Hemophilic Arthropathy
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials